Methyl 8-bromo-4-methoxyquinoline-2-carboxylate

Catalog No. :
ACSROZ139
CAS No. :
921760-93-2
Molecular Formula :
C12H10BrNO3
Molecular Weight :
296.12

IUPAC Name:methyl 8-bromo-4-methoxyquinoline-2-carboxylate

Methyl 8-bromo-4-methoxyquinoline-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$632.00Login to see priceInquiryInquiry
1g97%$1567.00Login to see priceInquiryInquiry
5g97%$4715.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 8-bromo-4-methoxyquinoline-2-carboxylate
IUPAC Namemethyl 8-bromo-4-methoxyquinoline-2-carboxylate
MDL No.MFCD16036787
Molecular FormulaC12H10BrNO3
Molecular Weight296.12
SMILESO=C(C1=NC2=C(Br)C=CC=C2C(OC)=C1)OC
InChI KeyJTKZAJSBTCSNPL-UHFFFAOYSA-N
Synonymmethyl 8-bromo-4-methoxyquinoline-2-carboxylate;2-Quinolinecarboxylic acid, 8-bromo-4-methoxy-, methyl ester;8-Bromo-4-methoxy-quinoline-2-carboxylic acid methyl ester;Methyl 8-bromo-4-methoxy-2-quinolinecarboxylate
CAS No.921760-93-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSROZ139 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSROZ139 route product structure diagram
    ACSROZ139921760-93-2
Inquiry

2. ACSROZ139 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACSROZ139 route product structure diagram
    ACSROZ139921760-93-2
Inquiry

Comments (0)